BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26195563)

  • 1. Pregnancy outcome for fetuses with increased nuchal translucency but normal karyotype.
    Lithner CU; Kublickas M; Ek S
    J Med Screen; 2016 Mar; 23(1):1-6. PubMed ID: 26195563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Birth defects associated with increased nuchal translucency].
    Mendoza-Caamal EC; Grether-González P; Hernández-Gómez M; Guzmán-Huerta M; Aguinaga-Ríos M
    Ginecol Obstet Mex; 2010 Oct; 78(10):533-9. PubMed ID: 21966770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
    Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population.
    Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased nuchal translucency at 11-14 weeks of gestation in congenital heart disease, genetic syndromes and adverse pregnancy outcome].
    Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Loquet P
    Akush Ginekol (Sofiia); 2005; 44(6):8-15. PubMed ID: 18982826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased fetal nuchal translucency thickness and normal karyotype: prenatal and postnatal follow-up].
    Saldanha FA; Brizot Mde L; Moraes EA; Lopes LM; Zugaib M
    Rev Assoc Med Bras (1992); 2009; 55(5):575-80. PubMed ID: 19918659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fetal abnormalities and prognosis associated with increased nuchal translucency and abnormal karyotype].
    Saldanha FA; Brizot Mde L; Lopes LM; Liao AW; Zugaib M
    Rev Assoc Med Bras (1992); 2009; 55(1):54-9. PubMed ID: 19360279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increased nuchal translucency with normal karyotype].
    Senat MV; Frydman R
    Gynecol Obstet Fertil; 2007 Jun; 35(6):507-15. PubMed ID: 17521948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
    Baś-Budecka E; Perenc M; Sieroszewski P
    Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
    Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
    Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased nuchal translucency and congenital heart defects in euploid fetuses. The Szeged experience.
    Orvos H; Wayda K; Kozinszky Z; Katona M; Pál A; Szabó J
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):124-8. PubMed ID: 11858885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome of euploid fetuses with increased nuchal translucency: how bad is the news?
    Maymon R; Weinraub Z; Herman A
    J Perinat Med; 2005; 33(3):191-8. PubMed ID: 15914340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and perinatal outcome of dichorionic and monochorionic twins with nuchal translucency above the 99(th) percentile and normal karyotype.
    Goncé A; Borrell A; Meler E; Arigita M; Martínez JM; Botet F; Sánchez A; Gratacós E
    Ultrasound Obstet Gynecol; 2010 Jan; 35(1):14-8. PubMed ID: 20033999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome for children born after a first-trimester measurement of increased nuchal translucency with a normal karyotype: a retrospective analysis.
    Axt-Fliedner R; Hartge D; Chiriac A; Krapp M; Berg C; Geipel A; Germer U; Gembruch U
    Ultraschall Med; 2009 Dec; 30(6):558-63. PubMed ID: 19137496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of fetuses with enlarged nuchal translucency and normal karyotype.
    Bilardo CM; Pajkrt E; de Graaf I; Mol BW; Bleker OP
    Ultrasound Obstet Gynecol; 1998 Jun; 11(6):401-6. PubMed ID: 9674085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disappearance of enlarged nuchal translucency before 14 weeks' gestation: relationship with chromosomal abnormalities and pregnancy outcome.
    Müller MA; Pajkrt E; Bleker OP; Bonsel GJ; Bilardo CM
    Ultrasound Obstet Gynecol; 2004 Aug; 24(2):169-74. PubMed ID: 15287055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
    Atzei A; Gajewska K; Huggon IC; Allan L; Nicolaides KH
    Ultrasound Obstet Gynecol; 2005 Aug; 26(2):154-7. PubMed ID: 15977311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.